Study on diltiazem hydrochloride controlled-release dosage forms / Ahmed Abdelrahman M. A. Elashmawy ; Supervised Nadia M. Mursi , Rania M. Badr Eldeen

By:

Ahmed Abdelrahman Mohamed Ahmed Elashmawy

Contributor(s):

Material type: Text

TextLanguage: eng Publication details: Cairo : Ahmed Abdelrahman Mohamed Ahmed Elashmawy , 2009Description: 258P. : charts , facsimiles ; 25cmOther title:

دراسة على الاشكال الصيدلية المنضبطة الانطلاق لعقار هيدروكلوريد الديلتيازيم [Added title page title]

Subject(s):

Online resources:

Click here to access online

Available additional physical forms:

Issued also as CD

Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics Summary: Diltiazem hydrochloride is a calcium channel blocker drug and widely prescribed at relatively high doses for the treatment of hypertension and angina. It is a freely water- soluble drug. The short half- life of diltiazem ranging from 3 to 5 hours requires multipe daily drug dosage in order to maintain adequate plasma concentrations

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Copy number	Status	Barcode
Thesis	قاعة الرسائل الجامعية - الدور الاول	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.08.08.Ph.D.2009.Ah.S (Browse shelf(Opens below))		Not for loan	01010110051748000
CD - Rom	مخـــزن الرســائل الجـــامعية - البدروم	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.08.08.Ph.D.2009.Ah.S (Browse shelf(Opens below))	51748.CD	Not for loan	01020110051748000

Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	Cai01.08.08.Ph.D.2008.Sa.P Pharmaceutical studies on certain topical sterile antibiotics /	Cai01.08.08.Ph.D.2008.Sh.P Pharmaceutical study on certain phosphodiesterase inhibitor /	Cai01.08.08.Ph.D.2008.Sh.P Pharmaceutical study on certain phosphodiesterase inhibitor /	Cai01.08.08.Ph.D.2009.Ah.S Study on diltiazem hydrochloride controlled-release dosage forms /	Cai01.08.08.Ph.D.2009.Ah.S Study on diltiazem hydrochloride controlled-release dosage forms /	Cai01.08.08.Ph.D.2009.Am.P A pharmaceutical study on metronidazole thermo and pH-sensitive controlled release drug delivery systems /	Cai01.08.08.Ph.D.2009.Am.P A pharmaceutical study on metronidazole thermo and pH-sensitive controlled release drug delivery systems /	Next

Thesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics

Diltiazem hydrochloride is a calcium channel blocker drug and widely prescribed at relatively high doses for the treatment of hypertension and angina. It is a freely water- soluble drug. The short half- life of diltiazem ranging from 3 to 5 hours requires multipe daily drug dosage in order to maintain adequate plasma concentrations

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer